REZENOPY

Growth

naloxone hcl

NDANASALSPRAY
Approved
Apr 2024
Lifecycle
Growth
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Feb 5, 2041
181 months away
Patent Expiry
Feb 5, 2041
Exclusivity Expiry
Apr 19, 2027

Patent Records (1)

Patent #ExpiryTypeUse Code
12514854
Feb 5, 2041
U-4397
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers